Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. Development of a Database Management System to Enable Rapid, Efficient Assay Design for Use in Detection and Diagnosis of Human Exposure to Biological

    SBC: CFD Research Corporation            Topic: CBD07114

    Increases in amount and diversity of high-throughput data presents tremendous organizational and analysis challenges to researchers. Our objective in this effort is to address these challenges by designing and implementing a database management system (cipherDB) for the storage, management, analysis, and visualization of diverse biological data types. The Phase I design and implementation of ciphe ...

    SBIR Phase II 2008 Department of DefenseOffice for Chemical and Biological Defense
  2. Reagentless and Realtime Detection of Airborne Microorganisms

    SBC: Lynntech Inc.            Topic: CBD06102

    Biological weapons are among the most serious threats facing the United States defense forces, today. Currently available bioaerosol sampling systems and cassettes require both sample preparation and a well equipped laboratory for analysis. Other detection methods rely on fragile bio-molecules for recognition of the target analyte. These systems are not suitable for onsite analysis. Infrared spec ...

    SBIR Phase II 2007 Department of DefenseOffice for Chemical and Biological Defense
  3. Self-Detoxifying, Disposable Protective Garments

    SBC: Lynntech Inc.            Topic: CBD06108

    While zero-based tolerance protective clothing is suitable for first responders, it provides an unnecessary level of protection for first receivers who are exposed to a considerably reduced threat. The use of zero-based tolerance garments by first receivers is particularly problematic since they often work in the same garments for an extended period of time. Consequently, the unique needs of fir ...

    SBIR Phase II 2007 Department of DefenseOffice for Chemical and Biological Defense
  4. Imidazenil: A Protective Agent Against Chemical Warfare Agents induced Status Epilepticus

    SBC: NEUPHARMA, INC.            Topic: CBD05116

    The overall objective of this Phase II proposal is to determine the advantages of imidazenil over diazepam or midazolam as a potential anticonvulsant agent for the prophylaxis and for the emergency treatment of organophosphate nerve agent exposure. Therefore, we will compare the dose-dependent efficacy and anticonvulsant tolerance liability of imidazenil or midazolam for protecting rats against di ...

    SBIR Phase II 2007 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government